BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/10/2017

FDA Clears Path for Nicardipine HCl Extended-Release Capsules to be Approved via Abbreviated New Drug Applications

The FDA has determined that CARDENE SR extended-release capsules in 30mg, 45mg, and 60mg doses were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval via abbreviated new drug applications

Source: Federal Register — Food and Drug AdministrationOpen original release →